Reduced expression of cyclin D2 was observed in breast cancer, non‐small cell lung cancer, pancreatic cancer and prostate cancer, indicating that cyclin D2 may act as a tumour suppressor in these cancers.36, 37, 38, 39. Here, CCND2 is linked to familial pancreatic carcinoma.